scanX
Home
Family Care Hospitals

Family Care Hospitals

5.01
+0.23
(4.81%)
Market Cap
25.80 Cr
EPS
2.32
PE Ratio
0.68
Dividend Yield
0.00 %
52 Week High
10.13
52 Week low
4.32
PB Ratio
1.79
Debt to Equity
0.08
Add Ratio
Live Chart

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Dr. Lal Path Labs
 2,599.50 21,944.10 52.68 2,295.80 11.52 362 19.34 32.26
Vijaya Diagnostic Centre
 994.10 9,492.20 66.93 568.60 20.11 120 35.77 46.90
Metropolis Healthcare
 1,652.50 8,603.20 56.46 1,216.80 4.59 129 15.38 32.43
Thyrocare Technologies
 725.75 3,817.30 43.48 581.30 8.63 70 29.25 37.05
Krsnaa Diagnostics
 727.80 2,404.10 31.81 636.40 25.65 57 49.23 33.04
Kilpest
 1,883.65 1,619.80 33.71 86.70 25.47 32 58.82 49.88
Sastasundar Ventures
 240.75 737.20 7.32 1,436.10 35.04 6 -1,081.25 33.27
One Global Service Provider
 297.80 207.30 18.07 63.00 248.07 7 133.33 54.85
Choksi Laboratories
 129.00 91.60 71.47 36.90 6.34 1 0.00 53.65
Aspira Pathlab
 65.89 66.50 78.78 13.60 -8.11 -3 142.86 40.93
Growth Rate
Revenue Growth
0.47 %
Net Income Growth
135.85 %
Cash Flow Change
92.97 %
ROE
87.28 %
ROCE
-5.51 %
EBITDA Margin (Avg.)
6.24 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
0
1
2
5
14
13
35
42
43
43
15
Expenses
0
1
2
4
13
11
28
34
34
33
56
EBITDA
-0
0
1
2
2
2
8
9
9
10
-41
Operating Profit %
-257 %
20 %
15 %
26 %
10 %
16 %
22 %
20 %
20 %
17 %
-1,732 %
Depreciation
0
0
0
0
1
1
1
1
1
1
1
Interest
0
0
0
0
1
1
1
0
1
0
0
Profit Before Tax
-25
0
0
1
0
0
6
7
7
8
-43
Tax
0
0
0
0
0
0
2
2
2
-4
-6
Net Profit
-25
0
0
1
0
0
4
5
5
13
-37
EPS in ₹
-17.63
0.01
0.05
0.27
0.01
0.01
1.27
1.62
1.64
2.32
-6.80
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
5
5
6
10
14
17
20
40
75
70
Fixed Assets
2
2
2
7
9
10
8
7
7
6
Current Assets
3
3
2
0
3
6
11
32
59
56
Capital Work in Progress
0
0
1
1
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
3
3
3
2
5
8
12
33
68
64
Total Liabilities
5
5
6
10
14
17
20
40
75
70
Current Liabilities
1
1
1
5
9
5
5
20
22
10
Non Current Liabilities
0
0
0
0
0
7
6
6
7
2
Total Equity
4
4
4
5
5
5
9
14
46
58
Reserve & Surplus
-28
-28
-28
-27
-27
-27
-23
-18
-8
4
Share Capital
32
32
32
32
32
32
32
32
54
54
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
3
-0
-0
-2
0
1
-1
-0
19
-2
Investing Activities
-2
-1
-2
-5
-2
-2
-0
-0
-2
-0
Operating Activities
-0
0
1
3
-4
-1
4
2
-5
-0
Financing Activities
5
0
1
0
6
5
-5
-2
26
-1
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Feb 2023
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
51.24 %
51.24 %
51.24 %
51.24 %
50.73 %
42.39 %
13.74 %
13.74 %
18.54 %
18.54 %
18.54 %
18.54 %
18.54 %
18.54 %
18.54 %
18.54 %
18.54 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.15 %
0.14 %
0.09 %
0.09 %
0.09 %
0.09 %
0.09 %
0.09 %
0.09 %
0.09 %
0.09 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
40.19 %
39.22 %
36.91 %
38.80 %
34.03 %
35.23 %
67.35 %
68.79 %
70.68 %
70.25 %
75.44 %
77.22 %
76.19 %
76.79 %
76.99 %
76.47 %
75.93 %
Others
8.42 %
9.39 %
11.70 %
9.81 %
15.09 %
22.23 %
18.76 %
17.32 %
10.69 %
11.12 %
5.94 %
4.15 %
5.18 %
4.58 %
4.38 %
4.90 %
5.44 %
No of Share Holders
3,835
3,875
4,337
6,814
7,781
23,255
37,905
35,665
35,042
34,489
37,798
39,157
38,892
41,956
42,155
45,369
48,177

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Technical Indicators

RSI(14)
Neutral
23.75
ATR(14)
Less Volatile
0.46
STOCH(9,6)
Neutral
21.49
STOCH RSI(14)
Oversold
12.79
MACD(12,26)
Bearish
-0.12
ADX(14)
Strong Trend
34.72
UO(9)
Bearish
41.31
ROC(12)
Downtrend But Slowing Down
-22.40
WillR(14)
Neutral
-78.10
Bearish
5
Neutral
2
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Fundamental Screeners
Technical Screeners
Candlestick Screeners
Intraday Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.